alexa Research Advances on the Treatment of Myoclonus-Dystoni
ISSN: 2155-9562

Journal of Neurology & Neurophysiology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Research Advances on the Treatment of Myoclonus-Dystonia Syndrome

Jie Fu*

Department of Neurology, The Hospital Affiliated of Luzhou Medical College, Sichuan, China

Corresponding Author:
Jie Fu
Department of Neurology
The Hospital Affiliated of Luzhou Medical College
Jiangyang Region, 25 Taiping Street
Luzhou, 646000, Sichuan, China
Tel: 8615181960975
E-mail: [email protected]

Received date: July 13, 2014; Accepted dat: September 06, 2014; Published date: September 15, 2014

Citation: Jie F (2014) Research Advances on the Treatment of Myoclonus-Dystonia Syndrome. J Neurol Neurophysiol 5:228. doi:10.4172/2155-9562.1000228

Copyright: © 2014 Fu J, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Myoclonus-Dystonia Syndrome is a movement disorder characterized by the association of myoclonus and
dystonia as the sole or prominent symptoms. Non-motor features may include obsessive-compulsive disorder,
depression, anxiety, personality disorders, alcohol abuse, and panic attacks. The pathogenesis of MDS is not very
clear, and the current opinions are mainly focus on gene mutations. The diagnosis is mainly based on clinical
features, and this disorder is confirmed by gene testing. Myoclonus-Dystonia Syndrome can’t be cured, and the
current therapy is mainly aimed to improve the symptoms, which includes medical and surgical treatment. All in all,
MDS remains poorly responsive to medical treatment. Although the surgical treatment develops very quickly in
recent years, due to the difficulty in predicting the range of operation and the large expense, surgical treatment is
hard to be implemented in clinical practice widely. Currently, medical treatment is still the main method, and the
surgery is considered when medication is ineffective.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords